CCZ1, or CCZ1 Homolog, is a protein involved in the regulation of vesicle trafficking processes within cells. Vesicle trafficking is a fundamental cellular mechanism that ensures the proper transport of proteins, lipids, and other molecules between different cellular compartments or between the cell and its external environment. This process is vital for numerous cellular functions, including nutrient uptake, waste disposal, and cell signaling. CCZ1, in association with other proteins, plays a role in the formation and fusion of vesicles, particularly in the context of endocytic pathways, which are processes that cells use to internalize molecules from their environment.
CCZ1 inhibitors would be molecules or strategies aimed at disrupting the function, expression, or stability of the CCZ1 protein. By inhibiting CCZ1, these molecules could potentially interfere with vesicle trafficking, leading to disruptions in the transport of molecules within cells. Given the central role of vesicle trafficking in many cellular processes, the consequences of such disruption could be multifaceted. Potential inhibitors of CCZ1 might include small molecules that bind directly to CCZ1, stopping its interaction with partner proteins or its involvement in vesicle formation and fusion. Another approach could involve molecules that modulate the expression of the CCZ1 gene, such as antisense oligonucleotides or tools leveraging RNA interference. Exploring the impacts of CCZ1 inhibition can provide insights into the specific roles of this protein in vesicle trafficking and elucidate the broader implications of modulating this vital cellular process. Understanding how CCZ1 functions and its interactions with other cellular components is key to appreciating the intricacies of vesicle trafficking and its significance in cellular biology.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a non-competitive inhibitor of dynamin, which is essential for endocytosis. Inhibiting endocytosis might affect CCZ1 expression due to disrupted protein trafficking. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine inhibits clathrin-mediated endocytosis. As endocytosis is upstream of endosomal sorting, CCZ1 expression might be affected. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3K, a kinase involved in vesicle trafficking. This can influence endosomal processes and potentially CCZ1 expression. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 inhibits the vacuolar ATPase (V-ATPase) and prevents acidification of vesicles. This might disrupt CCZ1-related processes and affect its expression. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that disrupts endosomal-lysosomal trafficking. This might influence CCZ1 expression due to disrupted protein sorting. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
U18666A can induce a phenotype resembling Niemann-Pick disease, affecting lysosomal function and potentially influencing CCZ1 expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein inhibits tyrosine kinases, which can be involved in various cellular signaling pathways, including vesicle trafficking that might impact CCZ1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 can affect vesicle trafficking pathways, which might indirectly impact CCZ1 expression. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-MA inhibits PI3K, and it's known to affect autophagy. Given the relationship between endosomes and autophagosomes, CCZ1 expression might be influenced. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Manumycin A inhibits Ras farnesyltransferase, affecting Ras signaling. This can influence various cellular processes, including potentially CCZ1 expression. | ||||||